| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.99e-05 | 18 | 75 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.56e-04 | 28 | 75 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.61e-04 | 37 | 75 | 3 | GO:0045505 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.04e-04 | 25 | 77 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.47e-04 | 238 | 77 | 6 | GO:0097729 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 4.30e-04 | 40 | 77 | 3 | GO:0005640 | |
| GeneOntologyCellularComponent | inner dynein arm | 5.91e-04 | 10 | 77 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | SCAR complex | 8.63e-04 | 12 | 77 | 2 | GO:0031209 | |
| GeneOntologyCellularComponent | dynein complex | 1.04e-03 | 54 | 77 | 3 | GO:0030286 | |
| MousePheno | abnormal circulating lipid level | SERPINA3 DMXL2 RINT1 OTC NCALD SORBS2 PIEZO2 REEP1 BZW2 FPR2 MGAT4A SERPINB2 PTPN23 GCGR ZC3H12C LRBA KIT CREBBP | 8.83e-06 | 1305 | 62 | 18 | MP:0003949 |
| Domain | KRAB_RELATED | 7.75e-08 | 11 | 75 | 4 | PS50806 | |
| Domain | Krueppel-associated_box-rel | 1.67e-07 | 13 | 75 | 4 | IPR003655 | |
| Domain | SSX | 1.23e-06 | 6 | 75 | 3 | IPR028804 | |
| Domain | SSXRD | 3.43e-06 | 8 | 75 | 3 | PF09514 | |
| Domain | SSXRD_motif | 3.43e-06 | 8 | 75 | 3 | IPR019041 | |
| Domain | Recoverin | 1.73e-05 | 13 | 75 | 3 | IPR028846 | |
| Domain | SCAR/WAVE_fam | 4.76e-05 | 3 | 75 | 2 | IPR028288 | |
| Domain | Znf_CCCH | 8.63e-05 | 58 | 75 | 4 | IPR000571 | |
| Domain | ZF_C3H1 | 8.63e-05 | 58 | 75 | 4 | PS50103 | |
| Domain | Glyco_transf_54 | 9.50e-05 | 4 | 75 | 2 | PF04666 | |
| Domain | Glyco_transf_54 | 9.50e-05 | 4 | 75 | 2 | IPR006759 | |
| Domain | WD40_repeat_dom | 1.89e-04 | 297 | 75 | 7 | IPR017986 | |
| Domain | CNMP_BINDING_1 | 2.84e-04 | 32 | 75 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 2.84e-04 | 32 | 75 | 3 | PS00889 | |
| Domain | RNase_Zc3h12a | 3.30e-04 | 7 | 75 | 2 | PF11977 | |
| Domain | eIF5C | 3.30e-04 | 7 | 75 | 2 | SM00515 | |
| Domain | RNase_Zc3h12_NYN | 3.30e-04 | 7 | 75 | 2 | IPR021869 | |
| Domain | W2 | 3.30e-04 | 7 | 75 | 2 | PF02020 | |
| Domain | W2 | 3.30e-04 | 7 | 75 | 2 | PS51363 | |
| Domain | W2_domain | 3.30e-04 | 7 | 75 | 2 | IPR003307 | |
| Domain | cNMP | 3.40e-04 | 34 | 75 | 3 | SM00100 | |
| Domain | cNMP_binding | 3.40e-04 | 34 | 75 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 3.71e-04 | 35 | 75 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 3.71e-04 | 35 | 75 | 3 | PS50042 | |
| Domain | G-protein_beta_WD-40_rep | 3.80e-04 | 85 | 75 | 4 | IPR020472 | |
| Domain | ARM-type_fold | 4.20e-04 | 339 | 75 | 7 | IPR016024 | |
| Domain | cNMP-bd-like | 4.74e-04 | 38 | 75 | 3 | IPR018490 | |
| Domain | WD40 | 6.07e-04 | 259 | 75 | 6 | PF00400 | |
| Domain | WD40 | 7.26e-04 | 268 | 75 | 6 | SM00320 | |
| Domain | WD40_repeat | 7.84e-04 | 272 | 75 | 6 | IPR001680 | |
| Domain | WD_REPEATS_1 | 8.78e-04 | 278 | 75 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 8.95e-04 | 279 | 75 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 8.95e-04 | 279 | 75 | 6 | PS50294 | |
| Domain | - | 9.45e-04 | 48 | 75 | 3 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 1.13e-03 | 51 | 75 | 3 | IPR014710 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.40e-03 | 14 | 75 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.40e-03 | 14 | 75 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.40e-03 | 14 | 75 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.40e-03 | 14 | 75 | 2 | PF08393 | |
| Domain | MT | 1.40e-03 | 14 | 75 | 2 | PF12777 | |
| Domain | AAA_8 | 1.40e-03 | 14 | 75 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.40e-03 | 14 | 75 | 2 | IPR011704 | |
| Domain | WH2 | 1.40e-03 | 14 | 75 | 2 | SM00246 | |
| Domain | AAA_5 | 1.40e-03 | 14 | 75 | 2 | PF07728 | |
| Domain | DHC_fam | 1.62e-03 | 15 | 75 | 2 | IPR026983 | |
| Domain | MIF4-like | 1.62e-03 | 15 | 75 | 2 | IPR016021 | |
| Domain | Dynein_heavy_dom | 1.62e-03 | 15 | 75 | 2 | IPR004273 | |
| Domain | - | 1.62e-03 | 15 | 75 | 2 | 1.25.40.180 | |
| Domain | Dynein_heavy | 1.62e-03 | 15 | 75 | 2 | PF03028 | |
| Domain | WH2 | 1.84e-03 | 16 | 75 | 2 | PF02205 | |
| Domain | - | 2.20e-03 | 333 | 75 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.27e-03 | 335 | 75 | 6 | IPR015943 | |
| Domain | UDPGT | 3.18e-03 | 21 | 75 | 2 | PF00201 | |
| Domain | WH2_dom | 3.18e-03 | 21 | 75 | 2 | IPR003124 | |
| Domain | UDPGT | 3.18e-03 | 21 | 75 | 2 | PS00375 | |
| Domain | UDP_glucos_trans | 3.18e-03 | 21 | 75 | 2 | IPR002213 | |
| Domain | EF-hand_1 | 3.27e-03 | 152 | 75 | 4 | PF00036 | |
| Domain | EFh | 3.76e-03 | 158 | 75 | 4 | SM00054 | |
| Domain | WH2 | 4.15e-03 | 24 | 75 | 2 | PS51082 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.78e-05 | 39 | 57 | 4 | MM15695 | |
| Pathway | WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2 | 3.38e-05 | 16 | 57 | 3 | M39484 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.71e-04 | 27 | 57 | 3 | M47755 | |
| Pubmed | Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. | 4.17e-08 | 4 | 77 | 3 | 10749136 | |
| Pubmed | 1.29e-07 | 21 | 77 | 4 | 12216073 | ||
| Pubmed | 5.80e-07 | 8 | 77 | 3 | 12007189 | ||
| Pubmed | ACSL4 FBXW10B DMXL2 FBXW10 DNAH10 SULT2A1 RBBP7 DNAH17 STK38 SUV39H2 CREBBP | 6.14e-07 | 730 | 77 | 11 | 34857952 | |
| Pubmed | 8.68e-07 | 9 | 77 | 3 | 14611804 | ||
| Pubmed | 2.82e-06 | 277 | 77 | 7 | 30745168 | ||
| Pubmed | 3.73e-06 | 14 | 77 | 3 | 9373155 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16546222 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 10222050 | ||
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 4.84e-06 | 2 | 77 | 2 | 31400758 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17263731 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 36333315 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29470543 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 37450367 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15319348 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16190876 | ||
| Pubmed | The Association Between WAVE1 and -3 and the ARP2/3 Complex in PC 3 Cells. | 4.84e-06 | 2 | 77 | 2 | 26977009 | |
| Pubmed | 8.31e-06 | 18 | 77 | 3 | 20056724 | ||
| Pubmed | Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. | 8.31e-06 | 18 | 77 | 3 | 20064376 | |
| Pubmed | 1.11e-05 | 225 | 77 | 6 | 12168954 | ||
| Pubmed | Deficiency in Fpr2 results in reduced numbers of Lin-cKit+Sca1+ myeloid progenitor cells. | 1.45e-05 | 3 | 77 | 2 | 30018139 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 34260931 | ||
| Pubmed | Genomic organization and expression profile of the human and mouse WAVE gene family. | 1.45e-05 | 3 | 77 | 2 | 12856283 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 7835904 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 29138287 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 19631450 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 9732292 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 15280206 | ||
| Pubmed | Characterization of the WAVE1 knock-out mouse: implications for CNS development. | 1.45e-05 | 3 | 77 | 2 | 12716942 | |
| Pubmed | SSX2-4 expression in early-stage non-small cell lung cancer. | 1.45e-05 | 3 | 77 | 2 | 24645645 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 22092298 | ||
| Pubmed | Expression and subcellular localization of WAVE isoforms in the megakaryocyte/platelet lineage. | 1.45e-05 | 3 | 77 | 2 | 15670045 | |
| Pubmed | ACSL4 RINT1 NCALD HPCAL1 KTN1 SYNE2 UBR4 NOC3L SCN9A DGKA ABCC5 MYBPC2 RPL18A | 1.57e-05 | 1442 | 77 | 13 | 35575683 | |
| Pubmed | 1.61e-05 | 504 | 77 | 8 | 34432599 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 27633918 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 32891959 | ||
| Pubmed | ArgBP2-dependent signaling regulates pancreatic cell migration, adhesion, and tumorigenicity. | 2.89e-05 | 4 | 77 | 2 | 18559503 | |
| Pubmed | Neutrophils establish rapid and robust WAVE complex polarity in an actin-dependent fashion. | 2.89e-05 | 4 | 77 | 2 | 19200726 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 17664349 | ||
| Pubmed | Pin1 Regulates IL-5 Induced Eosinophil Polarization and Migration. | 2.89e-05 | 4 | 77 | 2 | 33494375 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 16849011 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 10866654 | ||
| Pubmed | A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. | 2.89e-05 | 4 | 77 | 2 | 18178554 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 11175280 | ||
| Pubmed | Spermatogonia-dependent expression of testicular genes in mice. | 3.66e-05 | 29 | 77 | 3 | 12051830 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 27325740 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 37277019 | ||
| Pubmed | WAVE2 is required for directed cell migration and cardiovascular development. | 4.82e-05 | 5 | 77 | 2 | 12879075 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 15318931 | ||
| Pubmed | FBP11 regulates nuclear localization of N-WASP and inhibits N-WASP-dependent microspike formation. | 4.82e-05 | 5 | 77 | 2 | 14697212 | |
| Pubmed | SSX: a multigene family with several members transcribed in normal testis and human cancer. | 4.82e-05 | 5 | 77 | 2 | 9378559 | |
| Pubmed | Diversification of stem cell molecular repertoire by alternative splicing. | 6.49e-05 | 35 | 77 | 3 | 16183747 | |
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 25745180 | ||
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 25527710 | ||
| Pubmed | 8.49e-05 | 638 | 77 | 8 | 31182584 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 26074487 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 23575686 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.16e-04 | 857 | 77 | 9 | 25609649 | |
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 10381382 | ||
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 32093886 | ||
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 18052087 | ||
| Pubmed | Interaction of WASP/Scar proteins with actin and vertebrate Arp2/3 complex. | 1.34e-04 | 8 | 77 | 2 | 11146629 | |
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 10748067 | ||
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 18719240 | ||
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 20142249 | ||
| Pubmed | 1.72e-04 | 9 | 77 | 2 | 38981622 | ||
| Pubmed | 2.05e-04 | 1139 | 77 | 10 | 36417873 | ||
| Pubmed | 2.15e-04 | 10 | 77 | 2 | 11964161 | ||
| Pubmed | 2.15e-04 | 10 | 77 | 2 | 20388487 | ||
| Pubmed | The EHEC-host interactome reveals novel targets for the translocated intimin receptor. | 2.15e-04 | 10 | 77 | 2 | 25519916 | |
| Pubmed | 2.43e-04 | 251 | 77 | 5 | 27507650 | ||
| Pubmed | 2.50e-04 | 1168 | 77 | 10 | 19946888 | ||
| Pubmed | 2.68e-04 | 568 | 77 | 7 | 37774976 | ||
| Pubmed | 2.76e-04 | 963 | 77 | 9 | 28671696 | ||
| Pubmed | 2.91e-04 | 407 | 77 | 6 | 15772651 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 3.15e-04 | 12 | 77 | 2 | 20308471 | |
| Pubmed | A Prox1 enhancer represses haematopoiesis in the lymphatic vasculature. | 3.15e-04 | 12 | 77 | 2 | 36697821 | |
| Pubmed | 3.15e-04 | 12 | 77 | 2 | 18161889 | ||
| Pubmed | 3.15e-04 | 12 | 77 | 2 | 21402781 | ||
| Pubmed | 3.52e-04 | 272 | 77 | 5 | 31010829 | ||
| Pubmed | A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. | 3.71e-04 | 13 | 77 | 2 | 8625802 | |
| Pubmed | WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. | 3.71e-04 | 13 | 77 | 2 | 16723544 | |
| Pubmed | 4.32e-04 | 66 | 77 | 3 | 19898482 | ||
| Pubmed | 4.33e-04 | 14 | 77 | 2 | 17936260 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | BRIX1 ACSL4 RINT1 OTC KTN1 SYNE2 UBR4 THUMPD1 PIGU ME2 RPL18A | 4.42e-04 | 1496 | 77 | 11 | 32877691 |
| Pubmed | 5.28e-04 | 167 | 77 | 4 | 35833506 | ||
| Pubmed | FAIM DMXL2 SORBS2 HCN1 UBR4 RAPGEF4 ABCC5 LRBA MED13L CREBBP | 5.30e-04 | 1285 | 77 | 10 | 35914814 | |
| Pubmed | 6.15e-04 | 653 | 77 | 7 | 22586326 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 6.84e-04 | 665 | 77 | 7 | 30457570 | |
| Pubmed | 7.23e-04 | 18 | 77 | 2 | 36877072 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 7.45e-04 | 321 | 77 | 5 | 32098917 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 8.40e-04 | 498 | 77 | 6 | 36634849 | |
| Pubmed | 8.96e-04 | 20 | 77 | 2 | 21689717 | ||
| Pubmed | 9.02e-04 | 335 | 77 | 5 | 15741177 | ||
| Pubmed | 9.07e-04 | 193 | 77 | 4 | 19343046 | ||
| Pubmed | 9.68e-04 | 87 | 77 | 3 | 12465718 | ||
| Pubmed | 9.86e-04 | 708 | 77 | 7 | 39231216 | ||
| Pubmed | 1.09e-03 | 22 | 77 | 2 | 28963472 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.23e-03 | 736 | 77 | 7 | 29676528 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 1.26e-03 | 361 | 77 | 5 | 30344098 | |
| Cytoband | 4q13 | 2.87e-04 | 15 | 77 | 2 | 4q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 4.43e-04 | 377 | 77 | 5 | chrXp11 | |
| Cytoband | Xp11.23 | 5.62e-04 | 95 | 77 | 3 | Xp11.23 | |
| GeneFamily | Dyneins, axonemal | 1.76e-05 | 17 | 55 | 3 | 536 | |
| GeneFamily | WD repeat domain containing | 1.40e-04 | 262 | 55 | 6 | 362 | |
| GeneFamily | Mannosyl-glycoprotein N-acetylglucosaminyltransferases | 3.23e-04 | 9 | 55 | 2 | 435 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 4.91e-04 | 11 | 55 | 2 | 559 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 1.06e-03 | 16 | 55 | 2 | 14 | |
| GeneFamily | UDP glucuronosyltransferases | 4.25e-03 | 32 | 55 | 2 | 363 | |
| GeneFamily | EF-hand domain containing | 4.41e-03 | 219 | 55 | 4 | 863 | |
| GeneFamily | Zinc fingers CCCH-type | 5.07e-03 | 35 | 55 | 2 | 73 | |
| GeneFamily | Serpin peptidase inhibitors | 5.65e-03 | 37 | 55 | 2 | 739 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ACSL4 DMXL2 SETX HPCAL1 SYNE2 WASF3 SERPINB2 MED13L WASF1 ME2 CREBBP TIPARP | 6.20e-06 | 856 | 76 | 12 | M4500 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | BRIX1 ACSL4 DMXL2 SETX KTN1 SYNE2 MGAT4A NOC3L SCN9A DGKA THUMPD1 BZW1 LRBA WASF1 | 9.13e-06 | 1215 | 76 | 14 | M41122 |
| Coexpression | GSE17580_TREG_VS_TEFF_DN | 2.57e-05 | 200 | 76 | 6 | M3671 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 2.64e-05 | 201 | 76 | 6 | MM1294 | |
| Coexpression | MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP | 3.00e-05 | 61 | 76 | 4 | M1559 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 5.71e-08 | 200 | 77 | 7 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.31e-06 | 200 | 77 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd4+_Tnaive-Tcm)|Lymphoid / shred on cell class and cell subclass (v4) | 6.91e-06 | 153 | 77 | 5 | ffb8ac88513e83d3ba01574e60beb5476154372b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.44e-05 | 178 | 77 | 5 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-05 | 180 | 77 | 5 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 77 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 77 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 77 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.81e-05 | 90 | 77 | 4 | 27865bd63dda0624e62a3b713464a490b588d3ae | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.81e-05 | 90 | 77 | 4 | 8c2eb7444f938faade7c81a60c004252d588c80b | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.81e-05 | 90 | 77 | 4 | 4bc53b521abb79fc53ac912f1dc2e3c55426b2e0 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 190 | 77 | 5 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 190 | 77 | 5 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 190 | 77 | 5 | c0ee404d705b0b4f0c6ded4d070ad85eac4b16db | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 192 | 77 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 193 | 77 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-05 | 194 | 77 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-05 | 194 | 77 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.23e-05 | 195 | 77 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 198 | 77 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 198 | 77 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 198 | 77 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 198 | 77 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.42e-05 | 129 | 77 | 4 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.85e-05 | 135 | 77 | 4 | 4451c44f3ad788437f4e2ae81049fbbab53f967e | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.85e-05 | 135 | 77 | 4 | 45f67f33c8320d9fb6dbceae603b564f6a8ffd1e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 152 | 77 | 4 | 405d19b290232bb3e564d61c0cff0cfdd247bdff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 152 | 77 | 4 | 06fa7d8acc8f56de00af9bee17884595b300410e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.43e-04 | 153 | 77 | 4 | b101cb1bce5db785dab46b6c4f7be9c3efe48b0e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.43e-04 | 153 | 77 | 4 | 487388082bb596809ba1caf9197626b6814792ab | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Matrix_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.47e-04 | 154 | 77 | 4 | 928f49839b046b90c2f942458f3e365ddc4e0bc9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 155 | 77 | 4 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-dn_T|COVID-19_Severe / Disease group, lineage and cell class | 1.55e-04 | 156 | 77 | 4 | 83f25683e0f55472b56f915ee176fc05efc33a31 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 158 | 77 | 4 | f61ebe3a316e4259387cd9da83707f15e6473cae | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD8_TCM|Int-URO / Disease, Lineage and Cell Type | 1.62e-04 | 158 | 77 | 4 | edcc5a26d4571b179f3ae538fed23b661e4677dd | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 158 | 77 | 4 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 158 | 77 | 4 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.66e-04 | 159 | 77 | 4 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.66e-04 | 159 | 77 | 4 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 170 | 77 | 4 | be2a34c70665d8d11332b1a70eda03d77cb7f7dd | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 170 | 77 | 4 | 45de83a2231208b8e1f21061d0b91644b4a3ba93 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.30e-04 | 173 | 77 | 4 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-04 | 173 | 77 | 4 | b6aed736d8480e3a6a5718aabd2fb79b1b75fa48 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 2.40e-04 | 175 | 77 | 4 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 2.40e-04 | 175 | 77 | 4 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-04 | 177 | 77 | 4 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-04 | 178 | 77 | 4 | 5d6297f34e104bacefb25c4e2338b50fe13dd19a | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 2.67e-04 | 180 | 77 | 4 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-04 | 180 | 77 | 4 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.73e-04 | 181 | 77 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 181 | 77 | 4 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.78e-04 | 182 | 77 | 4 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.78e-04 | 182 | 77 | 4 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 182 | 77 | 4 | ccfee33de0faebbe69099d4ff3c3971f6a708b99 | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.78e-04 | 182 | 77 | 4 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-04 | 183 | 77 | 4 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-04 | 183 | 77 | 4 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.84e-04 | 183 | 77 | 4 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 184 | 77 | 4 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 184 | 77 | 4 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 184 | 77 | 4 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.90e-04 | 184 | 77 | 4 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 184 | 77 | 4 | e7b9c69fc77040c5191ad8089697051e2589c30e | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-04 | 184 | 77 | 4 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 185 | 77 | 4 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.02e-04 | 186 | 77 | 4 | a906020a8df6fcca474b278f746c553b177a56b4 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-04 | 186 | 77 | 4 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.02e-04 | 186 | 77 | 4 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-04 | 187 | 77 | 4 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-04 | 187 | 77 | 4 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.09e-04 | 187 | 77 | 4 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-04 | 187 | 77 | 4 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.09e-04 | 187 | 77 | 4 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-04 | 187 | 77 | 4 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-04 | 187 | 77 | 4 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 188 | 77 | 4 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.15e-04 | 188 | 77 | 4 | 986aaf31161ec3d1e6c76ee2dd17f44848a21f7e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-04 | 189 | 77 | 4 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-04 | 189 | 77 | 4 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.21e-04 | 189 | 77 | 4 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.21e-04 | 189 | 77 | 4 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.21e-04 | 189 | 77 | 4 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.21e-04 | 189 | 77 | 4 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.21e-04 | 189 | 77 | 4 | 033a2be8bbb7bfb437e6f1657b6ca02070c74aa8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 189 | 77 | 4 | 27e5d706f10a6221f314faf642eede15deab3165 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.28e-04 | 190 | 77 | 4 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 190 | 77 | 4 | ff3dec5b45c6ea9b5319fb51a0198c6773b7be26 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 3.28e-04 | 190 | 77 | 4 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 190 | 77 | 4 | 0bad41d19dc515e6bc61e699f4d56664cf2e72fd | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 3.28e-04 | 190 | 77 | 4 | 58a6ab70737d719ca9725ac087f20dfe9be0463e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-04 | 190 | 77 | 4 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 190 | 77 | 4 | 4971857eac9af17d66d673ed2ab7072639f60a10 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.34e-04 | 191 | 77 | 4 | 38fe60a8570f3c6eb8e8f8646f90d505dfd7d647 | |
| Drug | Biliton | 2.47e-07 | 41 | 76 | 5 | CID000002974 | |
| Drug | 3 SA | 1.06e-05 | 41 | 76 | 4 | CID000449164 | |
| Disease | X-24947 measurement | 2.16e-05 | 22 | 73 | 3 | EFO_0800910 | |
| Disease | nevus count, cutaneous melanoma | 7.83e-05 | 91 | 73 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | vitamin D deficiency | 1.06e-04 | 37 | 73 | 3 | EFO_0003762 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.15e-04 | 9 | 73 | 2 | C3502809 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 2.15e-04 | 9 | 73 | 2 | EFO_0600040 | |
| Disease | vitamin D measurement, COVID-19 | 2.47e-04 | 49 | 73 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | Connective Tissue Diseases | 4.63e-04 | 13 | 73 | 2 | C0009782 | |
| Disease | X-19141 measurement | 4.63e-04 | 13 | 73 | 2 | EFO_0800799 | |
| Disease | cutaneous melanoma, hair color | 4.95e-04 | 62 | 73 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | Lung diseases | 9.67e-04 | 78 | 73 | 3 | C0024115 | |
| Disease | Cholecystitis | 1.00e-03 | 19 | 73 | 2 | HP_0001082 | |
| Disease | androsterone glucuronide measurement | 1.11e-03 | 20 | 73 | 2 | EFO_0800317 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.35e-03 | 22 | 73 | 2 | DOID:2030 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKLILGNYKWMNYLE | 116 | O60488 | |
| KSVFLDQMKKFVEWL | 391 | Q9Y6E2 | |
| FFYEKISAWITKMEI | 531 | Q75V66 | |
| SVFLEQMKKFVEWLK | 391 | Q7L1Q6 | |
| VLVNYIFFKAKWEMP | 206 | P01011 | |
| DKTVEQKMKEILYWF | 111 | Q5XX13 | |
| EWYKKMLDKAFAERI | 1501 | Q92793 | |
| IYFEAKKKQDLYMWL | 116 | Q8TDN6 | |
| AALFYLSMKKKAVVW | 1666 | Q8TDJ6 | |
| KLMYFLVNFWKTNDL | 166 | P25092 | |
| DWKKLVQMKIYYFAA | 236 | Q9H3S7 | |
| QFLWEKYKRKKEYMN | 501 | Q7Z3E1 | |
| EKLRKAQDFYVEMKW | 121 | Q86YJ7 | |
| DKTVEQKMKEILYWF | 111 | O95170 | |
| FIFMFYKEKPIDWLL | 311 | Q9UM21 | |
| IAMKWLEFDQKRVKY | 236 | Q9H511 | |
| IEEWQYFYPMVLKKK | 236 | Q71F56 | |
| WMNKVKVLFKFTKVD | 511 | Q8NFG4 | |
| KYLQKPMYEVQWKVV | 546 | P10721 | |
| VWLKEMLFYGKYKII | 266 | P25090 | |
| EEIKYMLWLSADLKF | 51 | P00480 | |
| AQVMDFLFEKWKLYG | 26 | P47871 | |
| QEKMEQKLKWYFKLY | 86 | O95843 | |
| KLEQKLKWAFSMYDL | 96 | P37235 | |
| EKFNSRMKNKLWYFE | 546 | P23743 | |
| KFDFKPQKWYMVTIV | 291 | P50851 | |
| WLFMKETLYDEVLAK | 26 | Q86UP2 | |
| FSDFGLMWYLEELKK | 6 | Q96MN2 | |
| QYIPVKMKSKAFWIF | 211 | Q9H490 | |
| RFFLMFYKEKPIDWL | 306 | A6NG13 | |
| KIWKKNTPFLYDLVM | 21 | Q16576 | |
| VLTYIKFIKMYAWVK | 361 | O15440 | |
| KVIKMNYLKSWFVVD | 211 | O60741 | |
| KYAWFFFELLVKSMA | 981 | Q8NF50 | |
| KKYRNELMEKFWIPY | 3371 | Q9UFH2 | |
| IMKQKKEITEEVWYF | 3381 | Q8TD57 | |
| RKEWMFKLVGKETFY | 41 | Q9NVQ4 | |
| VMWFFKQKEKEDQVL | 71 | Q96AP7 | |
| EAQKKIWMFDKYGLL | 336 | P23368 | |
| IKSSQFWKYVMDEFK | 526 | Q8IVF4 | |
| FWKYVMDEFKIEVLI | 531 | Q8IVF4 | |
| KLEQKLKWAFSMYDL | 96 | P61601 | |
| KFYLENLEQMVKDWK | 306 | Q8WTT2 | |
| MVLVNAVYFKGKWKT | 196 | P05120 | |
| FRKSEKYMKLFLWLL | 386 | Q9H720 | |
| IFFMLWNNKYIKFVM | 256 | Q7RTR8 | |
| KDFKALWEKYRQYMA | 141 | Q8WZA2 | |
| SLWVVKMFYSFQDKL | 146 | Q15208 | |
| YQELKEKYKEMVKVW | 306 | Q8IYL2 | |
| KDFIKFIEFNAKKMW | 4396 | Q8WXH0 | |
| MYVKKVEKWGINQLF | 861 | Q9NTG1 | |
| KIFTYIFILEMLLKW | 1231 | Q15858 | |
| EWEKMKVSEKIVYVY | 36 | Q99909 | |
| FVKEVLKWKYEMFLN | 1701 | Q7Z333 | |
| DIKEYVKWMMYWIIF | 31 | Q9H902 | |
| NMKFIKKPKSWEEYF | 136 | Q06520 | |
| KSRFWYFVSQLKKMK | 41 | Q02543 | |
| VDRPKDWYKTMFKQI | 91 | O94875 | |
| EIKKRFKMVYVPNWF | 406 | Q8TAF3 | |
| EWEKMKASEKIFYVY | 36 | Q16385 | |
| FKIFWQMLVEKLDVY | 671 | Q6NUQ1 | |
| IFDMKKWDQFYSEVL | 226 | P06133 | |
| EWEKMKASEKIIYVY | 36 | O60225 | |
| EWEKMKSSEKIIYVY | 36 | Q7RTT3 | |
| KVVKDMEYYLVKWKG | 56 | Q9H5I1 | |
| YFFDLWKEKMLQDTE | 156 | Q9UPY6 | |
| LKFLEYFHKLQVFMW | 921 | Q9H5I5 | |
| WYKQEKKAPTFLFML | 56 | A0A075B6V5 | |
| IILYWKVIGDKFFIM | 106 | Q96MV1 | |
| WKKFIEERLLMYSFV | 311 | Q5HYM0 | |
| LDVEFYTLKKMFWQV | 106 | Q5TAH2 | |
| YFFDLWKEKMLQDTE | 156 | Q92558 | |
| WKKFIDERLLMYSFV | 366 | Q9C0D7 | |
| IFDMKKWDQFYSEVL | 226 | P16662 | |
| FWALVDLIYNMFKKV | 5096 | Q5T4S7 | |
| MKKYAETFLEPWFKA | 176 | Q9NXG2 | |
| CLMKYKQEVWKDLLY | 246 | Q9P2D8 | |
| GYFVQKADKKTMEWF | 966 | Q14324 |